Jayalakshmi Ravindran1, Barbra A Richardson2,3, John Kinuthia3,4, Jennifer A Unger3,5, Alison L Drake3, Lusi Osborn4, Daniel Matemo4, Janna Patterson6, R Scott McClelland3,7,8, Grace John-Stewart1,3,7,8. 1. Department of Pediatrics, University of Washington, Seattle, Washington, USA. 2. Department of Biostatistics, University of Washington, Seattle, Washington, USA. 3. Department of Global Health, University of Washington, Seattle, Washington, USA. 4. Kenyatta National Hospital, Nairobi, Kenya. 5. Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA. 6. Bill and Melinda Gates Foundation, Seattle, Washington, USA. 7. Department of Epidemiology, University of Washington, Seattle, Washington, USA. 8. Department of Medicine, University of Washington, Seattle, Washington, USA.
Abstract
BACKGROUND: Identifying predictors of preterm birth (PTB) in high-burden regions is important as PTB is the leading cause of global child mortality. METHODS: This analysis was nested in a longitudinal study of human immunodeficiency virus (HIV) incidence in Kenya. HIV-seronegative women enrolled in pregnancy had nucleic acid amplification tests (chlamydia and gonorrhea), rapid plasma reagin (syphilis), wet mount microscopy (Trichomonas and yeast), and Gram stain (bacterial vaginosis); sexually transmitted infection (STI) treatment was provided. PTB predictors were determined using log-binomial regression. RESULTS: Among 1244 mothers of liveborn infants, median gestational age at enrollment was 26 weeks (IQR, 22-31), and at delivery was 39.1 weeks (IQR, 37.1-40.9). PTB occurred in 302 women (24.3%). Chlamydia was associated with a 1.59-fold (P = .006), gonorrhea a 1.62-fold (P = .04), and incident HIV a 2.08-fold (P = .02) increased PTB prevalence. Vaginal discharge and cervical inflammation were associated with PTB, as were age ≤21 (prevalence ratio [PR] = 1.39, P = .001) and any STI (PR = 1.47, P = .001). Associations with chlamydia and incident HIV remained in multivariable models. CONCLUSIONS: STIs and incident HIV in pregnancy predicted PTB despite treatment, suggesting the need for earlier treatment and interventions to decrease genital inflammation.
BACKGROUND: Identifying predictors of preterm birth (PTB) in high-burden regions is important as PTB is the leading cause of global child mortality. METHODS: This analysis was nested in a longitudinal study of human immunodeficiency virus (HIV) incidence in Kenya. HIV-seronegative women enrolled in pregnancy had nucleic acid amplification tests (chlamydia and gonorrhea), rapid plasma reagin (syphilis), wet mount microscopy (Trichomonas and yeast), and Gram stain (bacterial vaginosis); sexually transmitted infection (STI) treatment was provided. PTB predictors were determined using log-binomial regression. RESULTS: Among 1244 mothers of liveborn infants, median gestational age at enrollment was 26 weeks (IQR, 22-31), and at delivery was 39.1 weeks (IQR, 37.1-40.9). PTB occurred in 302 women (24.3%). Chlamydia was associated with a 1.59-fold (P = .006), gonorrhea a 1.62-fold (P = .04), and incident HIV a 2.08-fold (P = .02) increased PTB prevalence. Vaginal discharge and cervical inflammation were associated with PTB, as were age ≤21 (prevalence ratio [PR] = 1.39, P = .001) and any STI (PR = 1.47, P = .001). Associations with chlamydia and incident HIV remained in multivariable models. CONCLUSIONS: STIs and incident HIV in pregnancy predicted PTB despite treatment, suggesting the need for earlier treatment and interventions to decrease genital inflammation.
Authors: Matthew K Hoffman; Shivaprasad S Goudar; Bhalachandra S Kodkany; Mrityunjay Metgud; Manjunath Somannavar; Jean Okitawutshu; Adrien Lokangaka; Antoinette Tshefu; Carl L Bose; Abigail Mwapule; Musaku Mwenechanya; Elwyn Chomba; Waldemar A Carlo; Javier Chicuy; Lester Figueroa; Ana Garces; Nancy F Krebs; Saleem Jessani; Farnaz Zehra; Sarah Saleem; Robert L Goldenberg; Kunal Kurhe; Prabir Das; Archana Patel; Patricia L Hibberd; Emmah Achieng; Paul Nyongesa; Fabian Esamai; Edward A Liechty; Norman Goco; Jennifer Hemingway-Foday; Janet Moore; Tracy L Nolen; Elizabeth M McClure; Marion Koso-Thomas; Menachem Miodovnik; R Silver; Richard J Derman Journal: Lancet Date: 2020-01-25 Impact factor: 79.321
Authors: Rebecca J Baer; Christina D Chambers; Kelli K Ryckman; Scott P Oltman; Larry Rand; Laura L Jelliffe-Pawlowski Journal: Sex Transm Dis Date: 2019-06 Impact factor: 2.830
Authors: Ana Paula Esteves Pereira; Marcos Augusto Bastos Dias; Maria Helena Bastos; Silvana Granado Nogueira da Gama; Maria do Carmo Leal Journal: BMC Res Notes Date: 2013-02-13
Authors: Milagros Ruiz; Peter Goldblatt; Joana Morrison; Lubomír Kukla; Jan Švancara; Marjo Riitta-Järvelin; Anja Taanila; Marie-Josèphe Saurel-Cubizolles; Sandrine Lioret; Chryssa Bakoula; Alexandra Veltsista; Daniela Porta; Francesco Forastiere; Manon van Eijsden; Tanja G M Vrijkotte; Merete Eggesbø; Richard A White; Henrique Barros; Sofia Correia; Martine Vrijheid; Maties Torrent; Marisa Rebagliato; Isabel Larrañaga; Johnny Ludvigsson; Åshild Olsen Faresjö; Daniel Hryhorczuk; Youriy Antipkin; Michael Marmot; Hynek Pikhart Journal: J Epidemiol Community Health Date: 2015-04-24 Impact factor: 3.710
Authors: Wenwen Jiang; Keshet Ronen; Lusi Osborn; Alison L Drake; Jennifer A Unger; Daniel Matemo; Daniel A Enquobahrie; John Kinuthia; Grace John-Stewart Journal: AIDS Date: 2022-03-04 Impact factor: 4.632
Authors: Christina Fennell; Modeigi Diseko; Rebecca Zash; Gloria Mayondi; Judith Mabuta; Mompati Mmalane; Sonya Davey; Rebecca Luckett; Chelsea Morroni; Eldah N Dintwa; Shahin Lockman; Joseph Makhema; Ellen Caniglia; Roger Shapiro Journal: Open Forum Infect Dis Date: 2021-07-09 Impact factor: 3.835
Authors: Anders Hviid; Anna Laksafoss; Paula Hedley; Ulrik Lausten-Thomsen; Henrik Hjalgrim; Michael Christiansen; Sjurdur Frodi Olsen Journal: JAMA Netw Open Date: 2022-02-01